BRIGHT MINDS BIOSCIENCES INC (DRUG): Institutional Ownership

Hedge funds and institutional managers reporting a position in DRUG · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
8
13F filers
Aggregate Value
$63.7M
Across holders
Last Price
$65.79
2026-06-26
Sector
Health Care
GICS
Holder activity3 new3 added2 reduced
Institutional Holders of DRUG
8 holders
ManagerTypeSharesMarket Value% of Total% of PortfolioActionQoQ ChangeQuarter
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK 0001165408
Hedge Fund496K$36.2M56.8%0.1%Added+$7.3MQ1 2026
BALYASNY ASSET MANAGEMENT LLC
CIK 0001218710
Hedge Fund297K$21.7M34.1%0.0%Added+$5.2MQ1 2026
Walleye Capital LLC
CIK 0001758720
Hedge Fund54K$3.9M6.2%0.0%Added+$2.0MQ1 2026
Schonfeld Strategic Advisors LLC
CIK 0001665241
Hedge Fund13K$966K1.5%0.0%Reduced$-1.2MQ1 2026
CITADEL ADVISORS LLC
CIK 0001423053
Hedge Fund6K$393K0.6%0.0%NewQ3 2025
RENAISSANCE TECHNOLOGIES LLC
CIK 0001037389
Hedge Fund4K$212K0.3%0.0%NewQ3 2025
TWO SIGMA INVESTMENTS, LP
CIK 0001179392
Hedge Fund3K$203K0.3%0.0%Reduced$-633KQ4 2025
MARSHALL WACE, LLP
CIK 0001318757
Hedge Fund2K$125K0.2%0.0%NewQ4 2025